Segment Information (Tables)

6 Months Ended

Jun. 30, 2023

Segment Reporting [Abstract]

Schedule of worldwide net revenues

The following table details AbbVie’s worldwide net revenues:

		Three months ended June 30,				Six months ended June 30,
(in millions)		2023		2022		2023		2022
Immunology
Humira	United States	$	3,452	$	4,664	$	6,400	$	8,657
	International	560		699		1,153		1,442
	Total	$	4,012	$	5,363	$	7,553	$	10,099
Skyrizi	United States	$	1,634	$	1,079	$	2,773	$	1,860
	International	249		173		470		332
	Total	$	1,883	$	1,252	$	3,243	$	2,192
Rinvoq	United States	$	645	$	412	$	1,094	$	723
	International	273		180		510		334
	Total	$	918	$	592	$	1,604	$	1,057
Hematologic Oncology
Imbruvica	United States	$	666	$	862	$	1,304	$	1,736
	Collaboration revenues	241		283		481		582
	Total	$	907	$	1,145	$	1,785	$	2,318
Venclexta	United States	$	265	$	253	$	530	$	481
	International	306		252		579		497
	Total	$	571	$	505	$	1,109	$	978
Aesthetics
Botox Cosmetic	United States	$	420	$	449	$	829	$	862
	International	265		246		515		474
	Total	$	685	$	695	$	1,344	$	1,336
Juvederm Collection	United States	$	125	$	147	$	247	$	295
	International	243		197		476		459
	Total	$	368	$	344	$	723	$	754
Other Aesthetics	United States	$	284	$	287	$	530	$	572
	International	47		45		87		83
	Total	$	331	$	332	$	617	$	655
Neuroscience
Botox Therapeutic	United States	$	614	$	557	$	1,201	$	1,057
	International	134		121		266		235
	Total	$	748	$	678	$	1,467	$	1,292
Vraylar	United States	$	657	$	492	$	1,217	$	919
	International	1		—		2		—
	Total	$	658	$	492	$	1,219	$	919
Duodopa	United States	$	24	$	26	$	49	$	50
	International	93		94		186		191
	Total	$	117	$	120	$	235	$	241
Ubrelvy	United States	$	194	$	185	$	344	$	323
	International	2		—		4		—
	Total	$	196	$	185	$	348	$	323

		Three months ended June 30,				Six months ended June 30,
(in millions)		2023		2022		2023		2022
Qulipta	United States	$	95	$	33	$	161	$	44
	International	1		—		1		—
	Total	$	96	$	33	$	162	$	44
Other Neuroscience	United States	$	65	$	145	$	140	$	318
	International	5		5		9		9
	Total	$	70	$	150	$	149	$	327
Eye Care
Ozurdex	United States	$	34	$	36	$	73	$	69
	International	85		74		161		148
	Total	$	119	$	110	$	234	$	217
Lumigan/Ganfort	United States	$	51	$	60	$	114	$	127
	International	68		70		135		143
	Total	$	119	$	130	$	249	$	270
Alphagan/Combigan	United States	$	32	$	54	$	60	$	124
	International	33		38		76		75
	Total	$	65	$	92	$	136	$	199
Restasis	United States	$	82	$	151	$	161	$	386
	International	17		17		30		28
	Total	$	99	$	168	$	191	$	414
Other Eye Care	United States	$	110	$	106	$	220	$	197
	International	105		111		195		191
	Total	$	215	$	217	$	415	$	388
Other Key Products
Mavyret	United States	$	193	$	203	$	364	$	372
	International	194		195		387		406
	Total	$	387	$	398	$	751	$	778
Creon	United States	$	282	$	318	$	587	$	605
Linzess/Constella	United States	$	269	$	247	$	520	$	480
	International	9		8		17		15
	Total	$	278	$	255	$	537	$	495
All other		$	741	$	1,009	$	1,432	$	2,220
Total net revenues		$	13,865	$	14,583	$	26,090	$	28,121